Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myriad Genetics

5.09
+0.17003.46%
Pre-market: 5.110.0200+0.39%07:10 EDT
Volume:1.69M
Turnover:8.58M
Market Cap:469.18M
PE:-4.55
High:5.17
Open:4.93
Low:4.93
Close:4.92
Loading ...

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

GlobeNewswire
·
07 Jan

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

GlobeNewswire
·
06 Jan

Tempus AI Stock Plunges 28.9% in Three Months: What's Next?

Zacks
·
25 Dec 2024

MYGN Stock Might Gain From the New Recognition of RiskScore Study

Zacks
·
20 Dec 2024

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

GlobeNewswire
·
20 Dec 2024

Is Myriad Genetics Stock a Smart Hold for Your Portfolio Right Now?

Zacks
·
17 Dec 2024

Myriad Genetics Is Maintained at Underperform by B of A Securities

Dow Jones
·
14 Dec 2024

Top Premarket Decliners

MT Newswires Live
·
12 Dec 2024

Myriad Genetics Inc : Jefferies Cuts Target Price to $13 From $15

THOMSON REUTERS
·
12 Dec 2024

Myriad Genetics Expects to Reach Resolution With UnitedHealthcare Over Pharmacogenetic Testing Before Yearend

MT Newswires Live
·
11 Dec 2024

Myriad Genetics Talks with UnitedHealthcare on Insurance Exclusion Might Extend Into 2025

Dow Jones
·
11 Dec 2024

Myriad Genetics provides an update on engagement with UnitedHealthcare

TIPRANKS
·
11 Dec 2024

BRIEF-Myriad Genetics Provides Update On Discussions With Unitedhealthcare Regarding Medical Policy For Pharmacogenetic Testing

Reuters
·
11 Dec 2024

Myriad Genetics Provides Update on Discussions With Unitedhealthcare Regarding Medical Policy for Pharmacogenetic Testing

THOMSON REUTERS
·
11 Dec 2024

Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing

GlobeNewswire
·
11 Dec 2024

BRIEF-Myriad Genetics Expands Board Of Directors With Election Of Mark S. Davis As New Board Member

Reuters
·
11 Dec 2024

Myriad Genetics : Approved an Increase in Size of Board From Eight to Nine Members

THOMSON REUTERS
·
11 Dec 2024

Myriad Genetics Expands Board of Directors With Election of Mark S. Davis as New Board Member

THOMSON REUTERS
·
11 Dec 2024

Press Release: Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member

Dow Jones
·
11 Dec 2024

Myriad Genetics’ Portfolio Elevated by Updated Nccn Prostate Cancer Guidelines

THOMSON REUTERS
·
10 Dec 2024